The journey doesn’t end after a clinical trial concludes, and Usahihi Therapeutics is committed to post-trial activities and lifecycle management. We monitor long-term drug safety and effectiveness through post-marketing surveillance (PMS), ensuring that our therapies continue to meet safety standards once in the market. We also explore opportunities for life cycle management, such as investigating additional indications, combination therapies, or reformulations to enhance the product’s value. Additionally, we protect our innovations by securing patents and managing intellectual property to preserve the value of proprietary drugs.
Post-Trial & Product Lifecycle:
- Post-Marketing Surveillance (PMS) – Monitoring long-term drug safety and effectiveness.
- Life Cycle Management – Exploring additional indications, combination therapies, or reformulations.
- Patent & Intellectual Property (IP) Management – Securing and maintaining patents for proprietary drugs.
Transform Your Vision into Reality
Contact Usahihi Therapeutics today to leverage our advanced services in clinical trials and therapeutic development. Start the conversation now and turn your idea into impact. Link to Contact Us page